NewsWhore
03-18-2009, 06:37 AM
AZN ) said Apr. 23 it would snap up the U.S. biotech for $15.2 billion, or $58 per share. MedImmune shares soared on the news to trade up 18% to close at $56.57 in Nasdaq trading Apr. 23. Shares ...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/22847016/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/22847016/)